Literature DB >> 17323132

The neuroendocrine physiology of kisspeptin in the human.

Waljit S Dhillo1, Kevin G Murphy, Stephen R Bloom.   

Abstract

Kisspeptin is a 54-amino acid peptide, encoded by the KiSS-1 gene, which activates the G protein-coupled receptor GPR54. Recent evidence suggests the kisspeptin/GPR54 system is a key regulator of reproduction. GPR54-deficient mice have abnormal sexual development. Central or peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal (HPG) axis in animal models. This review discusses the evidence that kisspeptin also plays a key role in human reproduction. Inactivating GPR54 mutations cause normosmic hypogonadotrophic hypogonadism in humans. Mutations which increase GPR54 signaling are associated with gonadotrophin-dependent premature puberty. Acute intravenous administration of kisspeptin to healthy human male volunteers potently increased plasma LH levels and significantly increased plasma FSH and testosterone without side effects. Plasma kisspeptin is found at low concentrations in the circulation of men and non-pregnant women, but is markedly increased in pregnancy. The placenta is believed to be the source of these high levels of circulating kisspeptin. The kisspeptin-GPR54 system is also implicated in tumour biology. Consistent with this role, plasma kisspeptin concentrations are elevated in patients with abnormal proliferation of placental tissue (gestational trophoblastic neoplasia or GTN) at presentation and fall after treatment with chemotherapy. The kisspeptin/GPR54 system therefore appears to play an important role in the regulation of reproduction in humans. Kisspeptin represents a novel tool for the manipulation of the HPG axis in humans and plasma kisspeptin may be a novel tumour marker in patients with GTN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323132     DOI: 10.1007/s11154-007-9029-1

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  35 in total

1.  KiSS-1 neurones are direct targets for leptin in the ob/ob mouse.

Authors:  J T Smith; B V Acohido; D K Clifton; R A Steiner
Journal:  J Neuroendocrinol       Date:  2006-04       Impact factor: 3.627

2.  Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats.

Authors:  Emily L Thompson; Kevin G Murphy; Michael Patterson; Gavin A Bewick; Gordon W H Stamp; Annette E Curtis; Jennifer H Cooke; Preeti H Jethwa; Jeannie F Todd; Mohammad A Ghatei; Stephen R Bloom
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-06-20       Impact factor: 4.310

3.  Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat.

Authors:  V M Navarro; J M Castellano; R Fernández-Fernández; S Tovar; J Roa; A Mayen; M L Barreiro; F F Casanueva; E Aguilar; C Dieguez; L Pinilla; M Tena-Sempere
Journal:  Endocrinology       Date:  2005-01-06       Impact factor: 4.736

4.  Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men.

Authors:  H Watanobe; T Nigawara; J Anzai; S Sakihara; K Kageyama; R Nasushita; S Sasaki; S Habu; K Takebe
Journal:  Biochem Biophys Res Commun       Date:  1994-04-29       Impact factor: 3.575

5.  Acute central stimulation of luteinizing hormone by parenterally administered N-methyl-D,L-aspartic acid in the male rat.

Authors:  B A Schainker; T J Cicero
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

6.  The GPR54 gene as a regulator of puberty.

Authors:  Stephanie B Seminara; Sophie Messager; Emmanouella E Chatzidaki; Rosemary R Thresher; James S Acierno; Jenna K Shagoury; Yousef Bo-Abbas; Wendy Kuohung; Kristine M Schwinof; Alan G Hendrick; Dirk Zahn; John Dixon; Ursula B Kaiser; Susan A Slaugenhaupt; James F Gusella; Stephen O'Rahilly; Mark B L Carlton; William F Crowley; Samuel A J R Aparicio; William H Colledge
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

7.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.

Authors:  Nicolas de Roux; Emmanuelle Genin; Jean-Claude Carel; Fumihiko Matsuda; Jean-Louis Chaussain; Edwin Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-27       Impact factor: 11.205

8.  The gonadotropin response of men with varicoceles to a four-hour infusion of gonadotropin-releasing hormone.

Authors:  R W Hudson; V A Crawford; D E McKay
Journal:  Fertil Steril       Date:  1981-11       Impact factor: 7.329

9.  Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications.

Authors:  Stephanie B Seminara; Meloni J Dipietro; Suresh Ramaswamy; William F Crowley; Tony M Plant
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

10.  The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal men.

Authors:  B C Fauser; J M Dony; W H Doesburg; R Rolland
Journal:  Fertil Steril       Date:  1983-05       Impact factor: 7.329

View more
  9 in total

1.  The effect of kisspeptin on the functional characteristics of isolated NK cells.

Authors:  S V Shirshev; I V Nekrasova; O L Gorbunova; E G Orlova; I L Maslennikova
Journal:  Dokl Biol Sci       Date:  2015-11-04

2.  Mutations in KISS1 are not responsible for idiopathic hypogonadotropic hypogonadism in Chinese patients.

Authors:  Yiming Zhang; Haobo Zhang; Yingying Qin; Yingchun Zhang; Xinxia Chen; Weiping Li; Zi-Jiang Chen
Journal:  J Assist Reprod Genet       Date:  2015-01-27       Impact factor: 3.412

Review 3.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

4.  The role of kisspeptin in immune tolerance formation during pregnancy.

Authors:  O L Gorbunova; S V Shirshev
Journal:  Dokl Biol Sci       Date:  2014-08-30

5.  Genome-Wide Association Study of Psychosis Proneness in the Finnish Population.

Authors:  Alfredo Ortega-Alonso; Jesper Ekelund; Antti-Pekka Sarin; Jouko Miettunen; Juha Veijola; Marjo-Riitta Järvelin; William Hennah
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 6.  Metabolic actions of kisspeptin signaling: Effects on body weight, energy expenditure, and feeding.

Authors:  Alexandra D Hudson; Alexander S Kauffman
Journal:  Pharmacol Ther       Date:  2021-09-14       Impact factor: 12.310

7.  KNDy Neurons Modulate the Magnitude of the Steroid-Induced Luteinizing Hormone Surges in Ovariectomized Rats.

Authors:  Cleyde V Helena; Natalia Toporikova; Bruna Kalil; Andrea M Stathopoulos; Veronika V Pogrebna; Ruither O Carolino; Janete A Anselmo-Franci; Richard Bertram
Journal:  Endocrinology       Date:  2015-08-24       Impact factor: 4.736

Review 8.  Sexual differentiation and the Kiss1 system: hormonal and developmental considerations.

Authors:  Alexander S Kauffman
Journal:  Peptides       Date:  2008-07-03       Impact factor: 3.750

9.  Prognostic value of metastin expression in human pancreatic cancer.

Authors:  Kazuyuki Nagai; Ryuichiro Doi; Fumihiko Katagiri; Tatsuo Ito; Atsushi Kida; Masayuki Koizumi; Toshihiko Masui; Yoshiya Kawaguchi; Kenji Tomita; Shinya Oishi; Nobutaka Fujii; Shinji Uemoto
Journal:  J Exp Clin Cancer Res       Date:  2009-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.